...
机译:口服双膦酸盐引起的颌骨坏死:发生率,临床特征,诱发因素和治疗结果
Department of Oral Pathology and Oral Medicine The Maurice and Gabriela Goldschleger School of Dental Medicine Tel Aviv University P.O. Box 39040 Tel Aviv 69978 Israel;
Department of Oral and Maxillofacial Surgery “Sheba” Medical Center Tel-Hashomer Israel;
Department of Oral and Maxillofacial Surgery “Sheba” Medical Center Tel-Hashomer Israel;
Department of Oral Medicine Hebrew University-Hadassah School of Dental Medicine Jerusalem Israel;
Department of Oral and Maxillofacial Surgery Hebrew University-Hadassah School of Dental Medicine Jerusalem Israel;
Department of Oral Medicine Hebrew University-Hadassah School of Dental Medicine Jerusalem Israel;
Alendronate; Bisphosphonate; Jaws; Osteomyelitis; Osteonecrosis; Osteoporosis;
机译:颌骨双膦酸盐相关性骨坏死的发生率,临床特征,预防和治疗建议
机译:颌骨双膦酸盐相关的骨坏死的发生率,临床特征,预防和治疗建议
机译:双膦酸盐相关的颌骨坏死:26例患者的临床特征,危险因素,管理和治疗结果。
机译:用骨切除和自体血小板血浆组合治疗颌骨双膦酸二族骨折:3例报告
机译:牙齿疾病和双膦酸盐诱导动物模型中颌骨的骨坏死
机译:评估双膦酸盐相关的颌骨坏死病例(包括骨活检)的诱发因素和手术治疗的相关结果
机译:口服双膦酸盐相关的颌骨坏死的替代疗法:一项比较富含生长因子和特立帕肽的纤维蛋白的试验研究